Supporting Materials New Insights into Targeting the CD200R1 Pathway in T and NK Cells Using 23ME-00610 as a Single Agent or in Combination 4.7 MB 23ME-01473, a novel anti-ULBP6/2/5 monoclonal antibody, reinvigorates anti-tumor NK cell function through NKG2D and FcγRIIIa activation 1.9 MB Discovery of ULBP6 as a Novel Immuno-Oncology Target Using Pleiotropic Signals from 23andMe’s Genetic and Health Survey Database 9.4 MB
New Insights into Targeting the CD200R1 Pathway in T and NK Cells Using 23ME-00610 as a Single Agent or in Combination 4.7 MB
23ME-01473, a novel anti-ULBP6/2/5 monoclonal antibody, reinvigorates anti-tumor NK cell function through NKG2D and FcγRIIIa activation 1.9 MB
Discovery of ULBP6 as a Novel Immuno-Oncology Target Using Pleiotropic Signals from 23andMe’s Genetic and Health Survey Database 9.4 MB
